A diagnosis of liver scarring sounds permanent, but the liver is one of the few organs that can clear away scar tissue once the damage stops. For most people, the cause of the scarring decides how much can heal, more than any treatment aimed at the scar itself. Curing hepatitis C, suppressing hepatitis B, losing substantial weight with fatty liver disease, and stopping alcohol can all let scarring shrink, even early cirrhosis. The chance of full recovery shrinks as scarring advances, so timing matters.
Why Liver Scarring Can Heal
Fibrosis is scar tissue the liver builds after repeated injury. Doctors grade it from F0 (none) to F4, which is cirrhosis. In cirrhosis, bands of scar have divided the liver into lumps of tissue walled off from one another.
The scar is made by certain liver cells that switch on when the liver is injured. When the injury stops, many of these cells die off naturally.1PubMed. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis In animal studies, nearly all the remaining scar-making cells gradually switched off over about two weeks of recovery.2PubMed Central. Deactivation of Hepatic Stellate Cells during Liver Fibrosis Resolution in Mice Immune cells then change into a repair type that digests scar tissue and calms inflammation.3PubMed. Macrophage heterogeneity in liver injury and fibrosis Because this repair system only gets going once the injury ends, healing depends on removing the cause first.
A skin scar usually stays for life, but liver scar is continually built and broken down. Scar-making cells lay down collagen while enzymes chew it up, and both go on at the same time. While injury continues, building outpaces breakdown and the scarring grows. Remove the injury and breakdown can win, so the scar slowly shrinks. Old, thick, heavily cross-linked scar is harder for those enzymes to break down than fresh, thin scar, which is one reason longstanding scarring heals more slowly.
In practice, reversal usually means dropping one or more grades, such as F3 to F2. It rarely means a liver returns to perfectly normal. Even a one-grade improvement can lower the risk of liver failure and cancer.
Reversal After Treating Hepatitis B or C
Modern hepatitis C pills cure most people in 8 to 12 weeks, and most studies show scarring shrinking once the virus is cleared.4PubMed Central. Fibrosis regression following hepatitis C antiviral therapy Among people with advanced scarring or cirrhosis, about 6 in 10 had softer livers after cure.5PubMed Central. Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C In livers re-biopsied after cure, the amount of scar tissue fell by almost half on average.6PubMed Central. Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C A softer liver on a scan doesn’t always mean the grade dropped, though. Only about 3 in 10 of those who improved on scans had improved below advanced scarring on biopsy.7PubMed Central. Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C Improvement can keep going for years after the cure.8PubMed Central. Fibrosis regression following hepatitis C antiviral therapy
Cure means the virus is gone from the blood months after treatment ends. That stops the ongoing injury, but it does not erase scarring that already exists. Someone with advanced scarring or cirrhosis before cure still needs periodic follow-up, because the liver may carry risks even with the virus gone. A common gene variant made scarring more likely to worsen even after cure, which is one reason checks continue. Cure does not protect against catching hepatitis C again.
Hepatitis B usually isn’t cured, but daily antiviral pills can keep it under control. After five years on tenofovir, about half of people had less scarring.9PubMed. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Of those who started with cirrhosis, about 3 in 4 no longer had cirrhosis after five years.10PubMed. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study People whose scarring improves on hepatitis B treatment have fewer liver complications later.11PubMed. Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
Those benefits came after years of uninterrupted treatment. Stopping antivirals can let the virus rebound and restart the injury, so ask your doctor before stopping, even if you feel well.
Reversal in Fatty Liver Disease Through Weight Loss
Fatty liver disease with inflammation, now called MASH (formerly NASH), is the most common cause of scarring in many countries. Excess fat in the liver drives the inflammation that causes scarring, so losing about 10% of body weight is linked to the best chance of scarring improving.
Smaller losses still help, since liver fat tends to fall first, though scarring generally needs more loss to budge. Crash dieting is not the goal; gradual loss is easier to keep off, and keeping it off matters because regained weight can bring liver fat and inflammation back.
Without surgery, steady loss through diet and activity works but is hard to sustain. Cutting sugary drinks and refined carbs reduces liver fat. Regular exercise reduces liver fat even with modest weight loss. Keeping diabetes and blood pressure under control helps protect the liver too.
Weight-loss surgery has the strongest results. After gastric bypass, inflammation cleared in 56% of people within a year, versus 16% with diet and exercise programs.12PubMed Central. Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review Overall, weight-loss surgery improved or cleared scarring in about 3 in 10 people.13Cleveland Clinic Journal of Medicine. Reversing fibrosis in metabolic dysfunction–associated steatohepatitis—beyond telling patients to lose weight
The liver kept improving for up to five years after surgery.14PubMed Central. Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review People whose scarring dropped to a low grade afterward had survival close to those who never had much scarring.15PubMed. Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study But people whose significant scarring persisted had about four times the risk of dying over 15 years.16PubMed. Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study
Surgery is usually offered to people with severe obesity, often with diabetes. It is a major operation with its own risks, so it is worth discussing with a weight-management or liver team.
Medicines That Can Reverse Fatty Liver Scarring
Resmetirom (Rezdiffra) is the first drug approved in the US for MASH with scarring, taken alongside diet and exercise.17PubMed. Insights into the results of Resmetirom trials: Can a thyroid hormone receptor agonist be the holy grail of MASH therapy? It is aimed at people whose fatty liver disease with inflammation has already caused moderate to advanced scarring, not at people with fatty liver alone. It is a daily pill, which makes it a different kind of treatment from weight-loss injections. After a year, about 1 in 4 people on it improved by at least one scarring grade, versus about 1 in 7 on a dummy pill.18PubMed Central. Resmetirom for MASH: A Comprehensive Review of a Novel Therapeutic Frontier It also reduced liver stiffness on scans.19PubMed Central. Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
Most people did not gain a full grade, so it is not a guaranteed fix. Improvement was measured over about a year, so longer-term results are still being learned.
With the weight-loss injection tirzepatide, about half of people improved at least one scarring grade, compared with 3 in 10 on a dummy pill.20PubMed. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis Semaglutide also beat a dummy pill for scarring improvement.21PubMed Central. Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis Several newer drugs are being tested and some look stronger, but they are not yet available.22PubMed Central. Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis The dummy-pill groups improved too, because people in trials also get diet and lifestyle advice; the drug adds benefit on top of it.
Useful questions for your doctor: whether your scarring stage qualifies you for resmetirom, whether weight-loss injections suit you given your diabetes or weight, and what cost and insurance coverage look like, since those can be a hurdle.
Reversal in Alcohol-Related and Other Liver Disease
Stopping alcohol is the single most important step for alcohol-related scarring. In people with alcohol-related cirrhosis, about 75% who quit were alive five years later, versus 50% who kept drinking.23PubMed Central. Reversal of liver cirrhosis: current evidence and expectations Direct evidence that the scar itself shrinks after quitting is limited, however.24PubMed Central. Reversal of liver cirrhosis: current evidence and expectations
Survival still improves because quitting stops new injury. Scarring that holds steady is itself a good outcome compared with scarring that keeps advancing. Quitting also lowers the risk of liver failure, and support programs and medicines can help people stop.
In mice, liver fat cleared quickly after alcohol stopped but the scar stayed.25PubMed Central. Alcohol-induced epigenetic changes prevent fibrosis resolution after alcohol cessation in mice It was an animal study, so it only suggests a pattern. In one trial, an antifibrosis drug reduced alcohol-related scarring in about a third of people, but it isn’t standard care.26PubMed Central. TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
Bile-duct disease can respond to targeted treatment. In primary biliary cholangitis, adding immune-calming drugs raised the share whose scarring improved from about 6% to about half, in people with active inflammation.27PubMed. Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis In a small group, obeticholic acid improved or held scarring steady in most people over three years.28News-Medical. OCA treatment stabilizes or reverses fibrosis/cirrhosis in patients with primary biliary cholangitis
Can Cirrhosis Be Reversed
Cirrhosis has been shown to regress, as in hepatitis B, where 3 in 4 people lost their cirrhosis. In advanced cirrhosis, though, whole areas of liver tissue die off and new liver cells regrow in disorganized lumps.29Frontiers in Medicine. What Makes Cirrhosis Irreversible?—Consideration on Structural Changes The original structure can’t rebuild, which may make advanced cirrhosis permanent.30Frontiers in Medicine. What Makes Cirrhosis Irreversible?—Consideration on Structural Changes
Doctors distinguish compensated from decompensated cirrhosis. Compensated means the liver still does its job without major symptoms. Decompensated means fluid in the belly, confusion, or bleeding. Reversal chances are much better before decompensation, and even without reversal, controlling the cause can stop worsening. Children’s livers seem especially able to heal if the cause is fixed early.31BMC Pediatrics. Balancing regeneration and scarring in pediatric liver fibrosis: key signalling pathways and potential therapeutic targets—a narrative review
Stem cell and macrophage infusions are being studied in trials, with early results showing safety and some benefit. Clinics selling unproven stem cell treatments are best avoided. Liver cancer screening usually continues even after improvement, typically an ultrasound every six months.
How You’ll Know If It’s Improving
A FibroScan measures liver stiffness, reported in kilopascals (kPa); higher means more scar. An MRI version called MR elastography does the same with different number ranges.32PubMed Central. Liver stiffness measured by either magnetic resonance or transient elastography is associated with liver fibrosis and is an independent predictor of outcomes among patients with primary biliary cholangitis In fatty liver disease, about a quarter of people had falling stiffness over time.33PubMed Central. CHANGE IN SERIAL LIVER STIFFNESS MEASUREMENT BY MAGNETIC RESONANCE ELASTOGRAPHY AND OUTCOMES IN NON-ALCOHOLIC FATTY LIVER DISEASE A lower stiffness reading doesn’t always mean the grade has dropped, though.34PubMed Central. Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C The reading can also rise for reasons other than scar, such as active inflammation, a recent heavy meal, or congestion from heart problems, so a doctor reads it alongside blood tests and your history.
FIB-4 is a score calculated from routine blood tests and age.35PubMed Central. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future The FIB-4 blood score is less reliable for tracking change over time than for first screening.36PubMed Central. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future Biopsy is the most direct test but is invasive and can miss areas.37PubMed Central. Histological assessment based on liver biopsy: the value and challenges in NASH drug development
Rechecks often happen every one to two years, depending on stage. Compare readings from the same machine type, and don’t panic over one small change, since trends matter more. Changes usually show over months to years. A viral cure may show softening within a year, while weight-loss benefits build over years.

